Compounds > tyrosine

tyrosine and Endomyocardial Fibrosis

tyrosine has been researched along with Endomyocardial Fibrosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, T; Kimura, S; Kitada, K; Kitaura, Y; Kobayashi, K; Kurumazuka, D; Matsuda, H; Matsumoto, C; Matsumura, Y; Mori, T; Shirakawa, H1
DeMarco, VG; Habibi, J; Ma, L; Pulakat, L; Rainey, WE; Sowers, JR; Whaley-Connell, AT1
Fernandez, AC; Harikrishnan, VS; Kumar, CS; Madhavachandran, V; Nair, RR; Sankar, V1
Amiri, F; Brassard, P; Iglarz, M; Javeshghani, DM; Pu, Q; Schiffrin, EL; Webb, RL1

Other Studies

4 other study(ies) available for tyrosine and Endomyocardial Fibrosis

ArticleYear
Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
    European journal of pharmacology, 2009, Nov-25, Volume: 623, Issue:1-3

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Body Weight; Cell Size; Contraindications; Diet, Sodium-Restricted; Endomyocardial Fibrosis; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transforming Growth Factor beta; Tyrosine; Ventricular Remodeling

2009
Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:4

    Topics: Animals; Blood Pressure; Cardiomegaly; Endomyocardial Fibrosis; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reactive Oxygen Species; Renin-Angiotensin System; Spironolactone; Tyrosine; Vasodilator Agents; Ventricular Dysfunction, Left

2011
Cardoguard, an Ayurvedic antihypertensive formulation, prevents cardiac remodeling in spontaneously hypertensive rats by inhibition of ERK and PKCĪµ signaling pathways.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:5

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiotonic Agents; Endomyocardial Fibrosis; Extracellular Signal-Regulated MAP Kinases; Heart; Hypertrophy, Left Ventricular; Male; MAP Kinase Signaling System; Medicine, Ayurvedic; Myocytes, Cardiac; Oxidative Stress; Protein Kinase C-epsilon; Rats; Rats, Inbred SHR; Rats, Wistar; Signal Transduction; Tyrosine; Ventricular Remodeling

2012
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Journal of hypertension, 2008, Volume: 26, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Endomyocardial Fibrosis; Endothelium, Vascular; Hydralazine; Hypertension; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Tetrazoles; Tyrosine; Valine; Valsartan

2008